1. Home
  2. TTC vs PCVX Comparison

TTC vs PCVX Comparison

Compare TTC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$94.40

Market Cap

9.3B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$54.19

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
PCVX
Founded
1914
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
6.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TTC
PCVX
Price
$94.40
$54.19
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$104.00
$98.33
AVG Volume (30 Days)
944.2K
1.0M
Earning Date
03-05-2026
05-06-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$2,618,650,000.00
N/A
Revenue This Year
$4.34
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$136.81
N/A
Revenue Growth
4.53
N/A
52 Week Low
$62.34
$28.09
52 Week High
$105.19
$76.61

Technical Indicators

Market Signals
Indicator
TTC
PCVX
Relative Strength Index (RSI) 41.08 41.91
Support Level $73.34 $42.30
Resistance Level $102.32 $56.04
Average True Range (ATR) 2.75 2.56
MACD -1.00 -0.89
Stochastic Oscillator 13.82 10.20

Price Performance

Historical Comparison
TTC
PCVX

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: